A randomized, controlled phase II clinical study evaluating the safety and efficacy of entinote combined with flavisten in the treatment of patients with advanced breast cancer that is hormone receptor positive and HER-2 negative
Latest Information Update: 04 Dec 2020
At a glance
- Drugs Entinote (Primary) ; Fulvestrant
- Indications Advanced breast cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Dec 2020 New trial record